LPPDS
A portable peritoneal dialysis system for home use that monitors for infection
Total Cost €
0EC-Contrib. €
0Partnership
0Views
0LPPDS project word cloud
Explore the words cloud of the LPPDS project. It provides you a very rough idea of what is the project "LPPDS" about.
Project "LPPDS" data sheet
The following table provides information about the project.
| Coordinator |
LIBERDI LTD
Organization address contact info |
| Coordinator Country | Israel [IL] |
| Project website | http://www.liberdi.com |
| Total cost | 71˙429 € |
| EC max contribution | 50˙000 € (70%) |
| Programme |
1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs) 3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies) |
| Code Call | H2020-SMEInst-2018-2020-1 |
| Funding Scheme | SME-1 |
| Starting year | 2018 |
| Duration (year-month-day) | from 2018-08-01 to 2018-11-30 |
Partnership
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | LIBERDI LTD | IL (MISGAV) | coordinator | 50˙000.00 |
Map
Project objective
End Stage Kidney Disease (ESKD) or End Stage Renal Disease (ESRD), the fifth and last stage of Chronic Kidney Disease (CKD), is recognised as a major public health problem. It occurs where kidneys are no longer capable of sufficiently filtering waste products from the blood. With kidney function at less than 10 %, a kidney transplant or an external means of filtering is needed. The latter consists of either Haemodialysis (HD) or Peritoneal Dialysis (PD). Globally, we are seeing an increasing prevalence in ESRD. This is caused by an aging population in the west, socio-economic factors, increasing hypertension, and growing diabetes and obesity epidemics.
The technical complexity of market offerings can inhibit many patients from choosing PD. HD takes an average of 4 hours per treatment session and occurs 3 times a week while PD occurs 4 times a day with each exchange requiring 40 minutes on average. Most dialysis occurs in specific dialysis centres and hospitals, adding further time for travel. Non-compliance with treatment schedules are a particular issue with PD. This makes it difficult for doctors to calculate correct treatment plans as patients may not share this information with their doctor. Non-compliance can be as high as 53%, decreasing efficacy of the treatment leading to poorer health overall and speeds up rate of decline.
liberDi revolutionises traditional Peritoneal Dialysis with LPPDS, a smart, real-time, patient-monitoring, truly portable device. It’s lightweight, easy to set up and allows patients carry out their dialysis at home, at work or while travelling. LPPDS has UX at the very core of its design to ensure ease of use: patent pending smart automation, catheters and sterile connectors. The system consists of a patent-pending disposable that holds a smart peristaltic pump designed to improve adherence to protocol, and reduce human errors, while saving time via fluid flow rate and management.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LPPDS" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "LPPDS" are provided by the European Opendata Portal: CORDIS opendata.
More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)
Totem Spoon (2019)
Interactive Digital Signage with emotional intelligence for smart cities
Read MoreWoodywood pickering (2019)
Bio-based (fully renewable) cost effective Polymer for new generation of ecological Coatings leveraging a disruptive innovation in the use of Pickering emulsion.
Read More